Kaplan–Meier analysis indicates high AIMP expression improves response to antiangiogenic therapy in glioblastoma, suggesting a potential predictive role.
High AIMP mRNA expression subgroups are more responsive to antiangiogenic therapies. Kaplan–Meier survival analysis on retrospective clinical trials of recurrent GBM (REGOMA and BELOB trials). High expression sub-groups are stratified by median mRNA expressions of AIMP1/2/3. A log-rank P value < 0.05 is considered significant.
No takes yet. Share an insight, caveat, or question.
Noor et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: